User profiles for Frank J.P. Hoebers
 | Frank HoebersRadiation Oncology (MAASTRO); Maastricht University; Brigham and Women's Hospital … Verified email at maastro.nl Cited by 11824 |
External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma
Background. Oropharyngeal squamous cell carcinoma (OPSCC) is one of the fastest growing
disease sites of head and neck cancers. A recently described radiomic signature, based …
disease sites of head and neck cancers. A recently described radiomic signature, based …
Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival
MC Van Harten, FJP Hoebers, KW Kross… - Oral oncology, 2015 - Elsevier
Introduction Waiting to start treatment has been shown to be associated with tumor progression
and upstaging in head and neck squamous cell carcinomas (HNSCCs). This diminishes …
and upstaging in head and neck squamous cell carcinomas (HNSCCs). This diminishes …
Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic …
G Thomas, S Ali, FJP Hoebers, KM Darcy… - Gynecologic …, 2008 - Elsevier
PURPOSE: To determine whether maintaining HGB levels ≥12.0 g/dL with recombinant
human erythropoietin (R-HUEPO) compared to “standard” treatment (transfusion for HGB ≤…
human erythropoietin (R-HUEPO) compared to “standard” treatment (transfusion for HGB ≤…
Intra‐arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial
…, JP de Boer, AH Ackerstaff, R Kroger, FJP Hoebers… - Cancer, 2010 - Wiley Online Library
BACKGROUND: Chemoradiation is the preferred treatment for advanced stage IV head and
neck cancer. Higher doses of chemotherapy yielded promising results in vitro and vivo, …
neck cancer. Higher doses of chemotherapy yielded promising results in vitro and vivo, …
99mTc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials
…, LW Stitt, JL Vanderheyden, FJP Hoebers… - European journal of …, 2015 - Springer
Purpose 99m Tc-Annexin A5 has been used as a molecular imaging probe for the visualization,
characterization and measurement of apoptosis. In an effort to define the quantitative …
characterization and measurement of apoptosis. In an effort to define the quantitative …
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study
…, M Bogowicz, A Jochems, FJP Hoebers… - The British journal of …, 2018 - birpublications.org
Objectives: Human papillomavirus (HPV) positive oropharyngeal cancer (oropharyngeal
squamous cell carcinoma, OPSCC) is biologically and clinically different from HPV negative …
squamous cell carcinoma, OPSCC) is biologically and clinically different from HPV negative …
In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response
…, RLM Haas, RAV Olmos, FJP Hoebers… - Radiotherapy and …, 2004 - Elsevier
BACKGROUND AND PURPOSE: Anticancer therapy induces apoptosis in a dose- and time-dependent
fashion. 99m Tc-Hynic-rh-Annexin V scintigraphy (TAVS) enables non-invasive …
fashion. 99m Tc-Hynic-rh-Annexin V scintigraphy (TAVS) enables non-invasive …
In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
Purpose: Increased tumor metabolism and hypoxia are related to poor prognosis in solid
tumors, including non–small cell lung cancer (NSCLC). PET imaging is a noninvasive …
tumors, including non–small cell lung cancer (NSCLC). PET imaging is a noninvasive …
[HTML][HTML] Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment
…, HP van der Laan, FJP Hoebers… - Radiotherapy and …, 2021 - Elsevier
Background and purpose A comprehensive individual toxicity risk profile is needed to improve
radiation treatment optimisation, minimising toxicity burden, in head and neck cancer (…
radiation treatment optimisation, minimising toxicity burden, in head and neck cancer (…
National protocol for model-based selection for proton therapy in head and neck cancer
JA Langendijk, FJP Hoebers… - … journal of particle …, 2021 - meridian.allenpress.com
In the Netherlands, the model-based approach is used to identify patients with head and
neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-…
neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-…
